首页|期刊导航|中国药业|研究者发起的临床研究风险评估与管控体系研究

研究者发起的临床研究风险评估与管控体系研究OA

Study on Risk Assessment and Control System for Investigator-Initiated Trials

中文摘要英文摘要

目的 基于风险管理模式构建研究者发起的临床研究(IIT)全流程风险评估与分级管控体系,并验证.方法 基于文献分析法检索中国知网(CNKI)、万方(WanFang)、Web of Science、PubMed数据库及互联网搜索工具等IIT相关文献、研究报告、现行管理政策等资料,检索时限为各数据库自建库起至 2023 年 12 月,建立IIT风险评估标准条目池初稿.采用德尔菲(Delphi)法对专家进行 2 轮咨询,确定最终的IIT全流程风险评估指标和分级管控体系,进行方法学评估,并结合真实世界研究和Spearman相关性分析验证指标体系的实用效能.结合地市级医院IIT项目管理现状,提出基于不同阶段、评估实施者、风险分级的分类、分级管控体系.结果 组建了由 17 名专家构成的Delphi咨询小组,以女性(12 名,70.59%)、工作年限>10 年(13 名,76.47%)、硕士研究生(8 名,47.06%)、高级职称(9 名,52.94%)、药物临床试验(GCP)主要研究者(9 名,52.94%)居多.2 轮Delphi咨询专家积极系数(问卷回收率)均为100%,专家权威系数分别为 0.953 和 0.965,专家意见集中程度分别为 4.495 分和 4.709 分,变异系数分别为 0.096 和 0.065.最终构建了涵盖立项、实施、结题全流程的IIT风险评估指标体系,包含 8 个一级指标、20 个二级指标及 36 个三级指标,且三级指标风险分级为一级风险点 8条、二级风险点 21条和三级风险点 7条.真实世界验证结果表明,构建的IIT风险评估指标体系与专家独立风险评分在全流程(ρ=0.894)、立项阶段(ρ=0.706)、实施阶段(ρ=0.761)、结题阶段(ρ=0.780)均呈极显著正相关(P<0.001).针对地市级医疗机构提出了基于风险等级的"归口管理+分级联动"差异化管控措施.结论 构建的IIT风险评估与管控体系具有较好的实用效能和评价一致性,可为地市级医疗机构开展IIT潜在风险点管理提供标准化工具支持,并为监管部门制订行业管理规范提供理论参考.

Objective To construct and verify a full-process risk assessment and hierarchical control system for investigator-initiated trials(IIT)based on the risk management model.Methods Literature analysis was used to retrieve IIT-related literatures,research reports,and current management policies from databases including CNKI,WanFang,Web of Science,PubMed,and internet search tools,with the retrieval period from the establishment of each database to December 2023.A preliminary pool of IIT risk assessment standard items was established.Two rounds of expert consultations were conducted using the Delphi method to determine the final full-process IIT risk assessment indicators and hierarchical control system.Methodological evaluation was performed,and the practical effectiveness of the indicator system was verified by combining real-world study and Spearman correlation analysis.Based on the current status of IIT project management in prefecture-level hospitals,a classified and hierarchical control system was proposed according to different stages,assessment implementers,and risk levels.Results A Delphi expert consultation group consisting of 17 experts was formed,with the majority being female(12 cases,70.59%),having work experience>10 years(13 cases,76.47%),holding a master's degree(8 cases,47.06%),possessing senior professional titles(9 cases,52.94%),and serving as principal investigators in good clinical practice(GCP)(9 cases,52.94%).The positive coefficients(questionnaire recovery rate)of the two rounds of Delphi consultations were both 100%,the expert authority coefficients were 0.953 and 0.965,the expert opinion concentration degrees were 4.495 points and 4.709 points,and the coefficients of variation were 0.096 and 0.065,respectively.Finally,a full-process IIT risk assessment indicator system covering project approval,implementation,and conclusion stages was constructed,including 8 first-level indicators,20 second-level indicators,and 36 third-level indicators.Among the third-level indicators,there were 8 first-level risk points,21 second-level risk points,and 7 third-level risk points.Real-world verification showed that the constructed IIT risk assessment indicator system was significantly positively correlated with independent expert risk scores in the full process(ρ=0.894),project approval stage(ρ=0.706),implementation stage(ρ=0.761),and conclusion stage(ρ=0.780)(P<0.001).Differentiated control measures of"centralized management+hierarchical linkage"based on risk levels were proposed for prefecture-level medical institutions.Conclusion The constructed IIT risk assessment and control system has good practical effectiveness and evaluation consistency,which can provide standardized tool support for prefecture-level medical institutions in managing potential risk points of IIT and theoretical reference for regulatory authorities in formulating industry management norms.

刘易陇;张晋;钟怡;周铃;胡红艳;王雪婷

四川省乐山市人民医院,四川 乐山 614000四川省乐山市人民医院,四川 乐山 614000四川省乐山市人民医院,四川 乐山 614000四川省乐山市人民医院,四川 乐山 614000四川省乐山市人民医院,四川 乐山 614000四川省乐山市人民医院,四川 乐山 614000

医药卫生

研究者发起的临床研究风险评估分级管控Delphi法真实世界研究

investigator-initiated trialrisk assessmenthierarchical controlDelphi methodreal-world study

《中国药业》 2026 (2)

34-40,7

四川省卫生健康委员会科技项目[23LCYJ056].

10.3969/j.issn.1006-4931.2026.02.007

评论